OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 05/20/2025 at 18:00, 1 year 2 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding shareholding percentages falling below thresholds. Atlas Special Opportunities II LLC sold voting securities affecting percentages. Visit www.oxurion.com for more info

Belgium Oxurion NV Transparency Notifications Shareholding Percentages Biofarmaceutical Company
PRESS RELEASE

published on 05/20/2025 at 18:00, 1 year 2 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding changes in share ownership per Belgian Transparency legislation. Oxurion is a biopharmaceutical company developing ophthalmic therapies

Biopharmaceutical Share Ownership Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/16/2025 at 08:35, 1 year 2 months ago

Oxurion to Acquire Majority Stake in Axiodis CRO

Acquisition Revenue Growth Oxurion Axiodis CRO Clinical Biometrics
BRIEF

published on 05/16/2025 at 08:35, 1 year 2 months ago

Oxurion va acquérir une participation majoritaire dans Axiodis CRO

Acquisition Croissance Des Revenus Oxurion Axiodis CRO Biométrie Clinique
PRESS RELEASE

published on 05/16/2025 at 08:30, 1 year 2 months ago

Oxurion kondigt de ondertekening aan van een bindende overeenkomst tot overname van de Franse biometriespecialist Axiodis CRO
Oxurion NV erwirbt 72% des Aktienkapitals von Axiodis CRO für 468.000 EUR, um das Unternehmen auf 650.000 EUR zu bewerten. Transaktionsschluss erwartet bis Ende Juni 2025

Übernahme Transaktion Oxurion NV Axiodis CRO Aktienkapital
PRESS RELEASE

published on 05/16/2025 at 08:30, 1 year 2 months ago

Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO
Oxurion NV to acquire 72% of Axiodis CRO shares for €468,000, valuing the company at €650,000. Deal expected to close by June 2025. Axiodis CRO specializes in clinical biometrics, offers integrated services for clinical trials, and aims for revenue growth

Acquisition Revenue Growth Oxurion NV Axiodis CRO Clinical Biometrics
PRESS RELEASE

published on 05/16/2025 at 08:30, 1 year 2 months ago

Oxurion annonce la signature de l'accord ferme d'acquisition du français Axiodis CRO, spécialiste français de la biométrie
Oxurion NV acquiert 72% d'Axiodis CRO, une CRO spécialisée en biométrie clinique. Axiodis CRO prévoit un CA de 970K€ en 2025 et vise 2M€ en 2027

Chiffre D'affaires Acquisition Oxurion NV Axiodis CRO Biométrie Clinique
BRIEF

published on 05/15/2025 at 18:05, 1 year 2 months ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Acquisition Actions Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 05/15/2025 at 18:05, 1 year 2 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 1 year 2 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notifications regarding changes in shareholding percentages to comply with Belgian transparency legislation. Details in attached PDF file

Shareholding Oxurion NV Belgian Legislation Transparency Notifications PDF File

Accesswire

Published on 08/08/2026 at 00:00, 15 hours 23 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 16 hours 8 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 16 hours 23 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 16 hours 53 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 17 hours 8 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 16 hours 2 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 19 hours 53 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 20 hours 8 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 21 hours 13 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 21 hours 23 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 20 hours 29 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 20 hours 29 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 20 hours 43 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 20 hours 43 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 21 hours 23 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE